Lord Abbett & CO. LLC Purchases 981,199 Shares of Mirion Technologies, Inc. (NYSE:MIR)

Lord Abbett & CO. LLC raised its holdings in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 70.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,368,734 shares of the company's stock after acquiring an additional 981,199 shares during the quarter. Lord Abbett & CO. LLC owned approximately 1.02% of Mirion Technologies worth $41,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. US Bancorp DE grew its holdings in Mirion Technologies by 3,248.7% during the fourth quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after purchasing an additional 6,075 shares during the period. SkyView Investment Advisors LLC bought a new position in shares of Mirion Technologies during the 3rd quarter valued at approximately $111,000. Tower Research Capital LLC TRC increased its holdings in Mirion Technologies by 162.9% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock worth $116,000 after acquiring an additional 4,120 shares in the last quarter. Harvest Fund Management Co. Ltd bought a new stake in Mirion Technologies during the 4th quarter worth approximately $120,000. Finally, KBC Group NV lifted its holdings in Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after purchasing an additional 2,254 shares in the last quarter. Institutional investors own 78.51% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on MIR. Robert W. Baird lowered their price objective on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, April 4th. B. Riley dropped their price target on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Finally, Citigroup reduced their price objective on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $18.75.

Mirion Technologies Price Performance

Mirion Technologies stock traded up $0.10 during mid-day trading on Thursday, reaching $15.88. 1,401,274 shares of the company's stock traded hands, compared to its average volume of 1,684,904. Mirion Technologies, Inc. has a 12-month low of $9.11 and a 12-month high of $18.81. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. The stock has a 50 day moving average of $14.47 and a two-hundred day moving average of $15.64. The company has a market cap of $3.69 billion, a price-to-earnings ratio of -83.61 and a beta of 0.75.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The firm had revenue of $202.00 million for the quarter, compared to analysts' expectations of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The business's revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.06 EPS. Equities analysts forecast that Mirion Technologies, Inc. will post 0.39 earnings per share for the current year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.